# Sanara Ventures

Sanara Ventures is a Venture Capital based in Ra'anana, Israel.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Ra'anana, Israel
- **Region:** Middle East
- **Address:** HaPnina St 8, Ra'anana, Israel 4321544
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** www.sanaraventures.com
- **LinkedIn:** https://www.linkedin.com/company/sanara-ventures

## Regulatory record

- **Reports private funds:** No

## About

Sanara Ventures is a seed-stage investment platform established in 2015 and backed by industry leaders Philips and Teva. Its follow-on fund Sanara Capital is a dedicated Health-Tech fund established in 2023, specializing in Digital Health, Bio-Convergence, and Medical Devices, focused on A & B financing rounds of Israeli related startups in Israel and abroad. The funds have nearly 20 active portfolio companies and provide 360 degrees of support and value creation through a core team, venture partners, and a global advisory board.

## Sectors

- Digital Health
- Medical Devices
- Bio-Convergence

## People

- Assaf Barnea — Founder & Managing Partner
- Yoav Shaked — Venture Partner
- Efi Hershkovitz — Venture Partner Israel/UK
- Dr. Janette Lazarowitz — Chief Biology Officer
- Dr. Eran Toledo — CTO
- Eli Yered — CFO
- Prof. Pinny Halpern — CMO
- Andrei Soran — Venture Partner US
- Daniel Kahn — Venture Partner EU
- Haisong Tang — Venture Partner China
- Tal Menipaz — Venture Partner
- David Ben-Ami — Venture Partner
- Dr. Jan Kimpen — Venture Partner
- Dr. Jonathan Seah — Venture Partner

## Questions

### How is Sanara Ventures related to Sanara Capital?

Sanara Capital is the follow-on fund launched in 2023, targeting Series A and B rounds in Israeli-linked health-tech startups. Sanara Ventures, established in 2015, is the seed-stage platform. Together they manage a combined portfolio of nearly 20 active companies, and both operate under the Sanara brand with the same managing partner.

### What is Sanara's relationship with Teva and Philips?

Teva Pharmaceuticals and Philips Healthcare are founding strategic partners that have backed Sanara Ventures since its 2015 launch. They do not function as limited partners in the traditional sense but provide industry connections, market understanding, and support across digital health, medical devices, and bio-convergence for portfolio companies (per the firm).

### Does Sanara participate in fund commitments or only direct deals?

Sanara operates exclusively as a direct investor. The firm runs two dedicated vehicles — a seed-stage platform and a Series A/B fund — and does not publicly indicate any fund-of-funds activity or LP commitments to external managers. All capital is deployed into company-level equity rounds.

### Which sectors does Sanara explicitly avoid?

Sanara focuses tightly on digital health, bio-convergence, and medical devices; the firm's public materials do not mention any activity in therapeutics, diagnostics outside its device-and-software lens, or health services outside technology-enabled care delivery. It does not appear to invest in generalist tech or non-healthcare verticals.

## Related profiles

- [Sanara Capital](https://altss.com/profile/sanara-capital)
- [Sanari Capital](https://altss.com/profile/sanari-capital)

---

Last updated: 2026-08-11T15:08:04.536Z

Canonical page: https://altss.com/profile/sanara-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology